Indo Amines' record carries a decade of unqualified audit opinions and clean CARO responses, with no fraud, wilful default, or statutory-dues defaults reported. The record's tension sits in control and cash: the company's own filings contradict whether Indo Speciality Chemicals is a subsidiary or an associate, and operating cash flow has converted only about half of EBITDA into cash over ten years.
Key findings
- Indo Amines' own filings contradict whether Indo Speciality Chemicals is a subsidiary or associate
Major- Indo Amines' stake in Indo Speciality Chemicals fell from 52.28% to 39.39% in FY2025-26 after it did not subscribe to a rights issue. The Board's Report says the entity became an Associate effective March 30, 2026, yet the consolidated financial statements continue to consolidate it as a subsidiary under Ind AS 110, citing control despite less than majority voting rights. The Directors' Report lists it as an Associate as on March 31, 2026. - Accounting-policy changes and NCLT amalgamations have repeatedly restated comparatives and boosted profit
Major- A depreciation-method switch from WDV to SLM effective 01-04-2020 lowered depreciation by ₹13.89 crore and increased FY2020-21 profit by ₹12.18 crore. The Pious Engineering amalgamation, approved by NCLT on 11 Nov 2024 with appointed date 1 Jan 2023, was accounted under the Pooling of Interest Method with prior-year figures restated. The company also changed its inventory valuation policy from FIFO to Weighted Average in FY2023-24, with the effect on net profit unascertainable. - Operating cash flow converted only about half of EBITDA into cash over a decade; free cash flow turned negative in FY2025
Major- Cumulative operating cash flow of ₹350 crore against cumulative operating profit of ₹643 crore gives a CFO/EBITDA conversion of 0.54x. FY2025 operating cash flow of ₹35.41 crore against PAT of ₹55.90 crore gives a CFO/PAT ratio of 0.63x, and free cash flow was negative at ₹-47.52 crore. Borrowing cost capitalised fell from ₹3.96 crore in FY2021 to ₹1.05 crore in FY2025, then rose to ₹1.31 crore in FY2026. - A promoter family holds three executive seats and has repeatedly secured approval for its own rising remuneration
Minor- Mr. Vijay Palkar (Managing Director & CEO), Mrs. Bharati Palkar (Whole-Time Director), and Mr. Rahul Palkar (Joint Managing Director) are immediate relatives serving together on the board. A postal ballot on 17 July 2026 approved remuneration increases for Mr. Vijay Palkar (97.50% in favour) and Mr. Rahul Palkar (97.80% in favour), with promoter-group shareholders voting 100% in favour even where declared interested parties. Independent directors turn over frequently: Mr. Vijay Sane resigned effective April 16, 2026, less than one year into his second term. - Statutory auditor resigned mid-tenure in November 2023; fees have since risen roughly 13-fold
Minor- M/s. V S Somani & Co. resigned as statutory auditor with a letter dated 02 November 2023, and the Board appointed M/s. Kulkarni & Khanolkar on 09 November 2023 to fill the casual vacancy. Shareholders ratified Kulkarni & Khanolkar for five years at the 31st AGM, with 5,01,78,843 votes in favour (100.00%). Total auditor fees rose from ₹10,29,875 in FY2022-23 to ₹20,05,000 in FY2025-26. - Seven years of unqualified opinions and clean CARO responses, with a recurring caveat on subsidiary audit coverage
Minor- The standalone and consolidated audit opinions were unqualified in each year from FY2019-20 through FY2025-26. CARO reported no fraud, no wilful-defaulter declaration, and no default in loan repayment in each of those years. In FY2024-25, the consolidated report disclosed that Indo Speciality Chemicals, Indo Amines (Malaysia) and Indo Amines (Europe) were audited by other auditors (total assets ₹44.94 crore, revenues ₹75.77 crore), while Indo Amines LLC and Indo Amines (Changzhou) were unaudited and furnished by Management (total assets ₹29.16 crore, revenues ₹84.53 crore). - Modest capital commitments and an unresolved insurance receivable from a 2024 plant fire
Minor- Capital commitments (net of advances) stood at ₹38.93 lakh in FY2025-26, down from ₹5.07 crore in FY2024-25. A fire at the W-35 plant in Dombivli on 12 June 2024 destroyed inventory of ₹2.6 crore and damaged property with a book value of ₹3.36 crore, both shown as receivables from the insurance company in FY2024-25 and FY2025-26. Auditors consistently report no material pending litigations impacting financial position. - A single minor BSE fine in FY2022 is the only regulator action disclosed
Minor- Indo Amines paid a fine of ₹21,240 (₹18,000 plus ₹3,240 GST) to BSE in FY2021-22 for not obtaining shareholder approval of the age limit of Independent Director Mr. Nishikant Sule under Regulation 17(1A) of SEBI LODR. The FY2024-25 Board's Report states no penalties or strictures were imposed by Stock Exchanges, SEBI or statutory authorities in the last three years. A certificate dated August 12, 2026 confirms none of the directors were debarred or disqualified for FY ending March 31, 2026.
What to watch
- Independent director regularization. The 33rd AGM votes on regularizing Mr. Rahul Chitnis for one year from July 15, 2026.
- Insurance claim outcome. The receivable for the 12 June 2024 Dombivli W-35 plant fire remains open as of the FY2025-26 Annual Report.
- Pious Engineering amalgamation completion. Transfer of contingent liabilities and share allotment remain pending as of the 27 November 2024 announcement.
- FY2026-27 free cash flow. Whether it recovers from the negative ₹-47.52 crore reported in FY2024-25.
Bottom line: This is a disclosed, audited record with a decade of unqualified opinions and a single minor BSE fine of ₹21,240 in FY2022 as the only regulator action disclosed. The risk character is control ambiguity and cash conversion: the company's own filings contradict the status of Indo Speciality Chemicals, and cumulative operating cash flow converted only about half of EBITDA into cash over a decade. Watch the AGM outcome on the subsidiary classification and whether free cash flow turns positive.